Varaico: Literature-Extracted Genetic Variants

Gene:PHLPP2
Variant:p.L1016S
Back to variants list

PHLPP2

NM_015020.3:p.L1016S

Associated Papers

Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma.

Villa M et al.

British Journal of Cancer, 2024

39478125 (PubMed )
Supplement: 41416_2024_2881_MOESM1_ESM.pdf

PHLPP2 gene L1016S (rs61733127) and PIK3R1 gene Met326Ile (rs3730089) polymorphisms are associated with the risk of colon and breast cancers.

Daneshvar G et al.

Nucleosides, Nucleotides & Nucleic Acids, 2021

An insight into the molecular genetics of a uveal melanoma patient cohort.

Kennedy S et al.

Journal of Cancer Research and Clinical Oncology, 2018

Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells.

Chen HH et al.

The Journal of Allergy and Clinical Immunology, 2017

Polymorphisms associated with everolimus pharmacokinetics, toxicity and survival in metastatic breast cancer.

Pascual T et al.

Plos One, 2017

Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.

Kopetz S et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 2015

26460303 (PubMed )
Supplement: supp_33.34.4032_DS_2015.632497.pdf

Functional polymorphisms in cancer.

Agarwal D et al.

Oncoscience, 2015

XomAnnotate: Analysis of Heterogeneous and Complex Exome- A Step towards Translational Medicine.

Talukder AK et al.

Plos One, 2015

25905921 (PubMed )
Supplement: pone.0123569.s008.xls › BC4_ERR166308

An association-adjusted consensus deleterious scheme to classify homozygous Mis-sense mutations for personal genome interpretation.

Preeprem T et al.

Biodata Mining, 2013

24365473 (PubMed )
Supplement: 1756-0381-6-24-S2.xlsx › Additional_Table_7

Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas.

Griewank KG et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2013

23633454 (PubMed )
Supplement: 10780432ccr130163-sup-tab1-3.pdf

Frequency of mutations and polymorphisms in borderline ovarian tumors of known cancer genes.

Stemke-Hale K et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2013

Suppression of survival signalling pathways by the phosphatase PHLPP.

O'Neill AK et al.

The Febs Journal, 2013

Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers.

Santarpia L et al.

Breast Cancer Research and Treatment, 2012

Common polymorphism in the phosphatase PHLPP2 results in reduced regulation of Akt and protein kinase C.

Brognard J et al.

The Journal of Biological Chemistry, 2009

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."